Tildrakizumab-Asmn
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Drugs for plaque psoriasis.
Journal: The Medical letter on drugs and therapeutics
Published: September 20, 2024
Comparison table: Some drugs for plaque psoriasis.
Journal: The Medical letter on drugs and therapeutics
Published: September 20, 2024
Long-Term Efficacy of Tildrakizumab in the Treatment of Psoriasis.
Journal: Skin therapy letter
Published: May 23, 2024
Bimekizumab (Bimzelx) for psoriasis.
Journal: The Medical letter on drugs and therapeutics
Published: January 11, 2024
Successful management of treatment resistant nail psoriasis with tildrakizumab.
Journal: The Australasian journal of dermatology
Published: March 08, 2021
Expanded table: some drugs for psoriasis.
Journal: The Medical letter on drugs and therapeutics
Published: August 06, 2019
Risankizumab (Skyrizi) for psoriasis.
Journal: The Medical letter on drugs and therapeutics
Published: June 07, 2019
Tildrakizumab: A Review in Moderate-to-Severe Plaque Psoriasis.
Journal: American journal of clinical dermatology
Published: March 30, 2019
Tildrakizumab (Ilumya) - another IL-23 antagonist for psoriasis.
Journal: The Medical letter on drugs and therapeutics
Published: January 26, 2019
Last Updated: 04/28/2026